Parenteral Drug Association
Connecting People, Science and Regulation ®
by: Christoph Bredack, PhD, Genedata
by: Lucia Ceresa
by: Parampal Deol
Matthew M. Lowe, MasterControl
Kurt Brorson and Sau L. Lee, U.S. FDA
Rebecca Stauffer, PDA
Jacqueline Kunzler, PhD, Baxter International Inc.
Stephanie Gaulding, DPS Engineering
Walter Morris, PDA
Rafik H. Bishara, PhD, Eli Lilly and Company (retired) and Erik van Asselt, PhD, MSD
Robert A. Schaut, PhD, and W. Porter Weeks, Corning Incorporated
Roy Cherris, Bridge Associates International
Ursula Busse, PhD, Novartis, and Steffen Gross, Paul-Ehrlich-Institut
Mathias Romacker, Pfizer, and Hanns-Christian Mahler, Lonza
Kathleen Souza, MilliporeSigma
Nrupa Patel, Teligent Pharma Inc., and Sandip Patel, Navinta LLC
Wendy Saffell-Clemmer, Baxter Healthcare
Anders Vinther, Sanofi Pasteur; Emma Ramnarine, Genentech; co-chairs PDA Post Approval Change: Innovation for Availability of Medicines (PAC iAM) Task Force
Stefan Kleinmann, PhD, METALL+PLASTIC, Matthias Scheu, METALL+PLASTIC, Roland Schuhwerk, Cilag AG, and Volker Baur, Cilag AG
Susan Schniepp, Regulatory Compliance Associates, and Steven Mendivil, Amgen
Toni Manzano, bigfinite
Egmont Semmler, Groninger & Co.
John Shabushnig, PhD, Insight Pharma Consulting, and Markus Lankers, PhD, rap.ID Particle Systems GmbH
PDA Japan Chapter Annual Meeting Committee
Brittany Cloud, Eurofins Lancaster Laboratories, Inc.
Lee Leichter, P/L Biomedical
Andy Fry, Team Consulting
Thomas R. Kreil, PhD, Global Pathogen Safety, Shire
Colleen Walson-Billin, Amgen
Yingying Liu, ECURAC, and Siegfried Schmitt, PAREXEL
Geert Vandenbossche, Novartis; Marc Besson, Sanofi; Gabriele Gori, GSK Vaccines; Jette Christensen, Novo Nordisk; Gerry Morris, Eli Lilly and Company
Riccardo Luigetti, EMA, Emer Cooke, EMA, Brendan Cuddy, EMA, Sebastien Goux, European Commission, and Ian Rees, MHRA
Hal Baseman, Marsha Hardiman, Walter Henkels and Mike Long, ValSource
PDA Post Approval Change: Innovation for Availability of Medicines (PAC iAM) Task Force
Doug Chambers, MilliporeSigma
Crystal Mersh, Quality Executive Partners
John Godshalk, Biologics Consulting
Anders Vinther, PhD, Sanofi Pasteur